PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.\', \'Department of Pediatrics, Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, New York-Presbyterian Morgan Stanley Children\'s Hospital, Columbia University Medical Center, New York, New York, USA.\', \'Division of Pediatric Hematology and Oncology, Weill Cornell Medicine, New York, New York, USA.\', \'Division of Pediatric Hematology, Oncology and Cellular Therapy, Children\'s Hospital at Montefiore, Bronx, New York, USA.\', \'Department of Pediatrics, Division of Pediatric Hematology-Oncology, Mount Sinai Kravis Children\'s Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Division of Pediatric Hematology Oncology, Northwell Health, Staten Island University Hospital, Staten Island, New York, USA.\', \'Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/pbc.29088
?:hasPublicationType
?:journal
  • Pediatric blood & cancer
is ?:pmid of
?:pmid
?:pmid
  • 33913620
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • COVID-19 has changed the way we think about training future pediatric hematologists/oncologists.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all